Herriot Tabuteau is Chief Executive Officer of Axsome Therapeutics, Inc.. Currently has a direct ownership of 7,229 shares of AXSM, which is worth approximately $1.01 Million. The most recent transaction as insider was on Jan 07, 2026, when has been sold 31,261 shares (Common Stock) at a price of $170.38 per share, resulting in proceeds of $5,326,249. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.23K
0% 3M change
n/a 12M change
Total Value Held $1.01 Million

HERRIOT TABUTEAU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2026
SELL
Open market or private sale
$5,326,249 $170.38 p/Share
31,261 Reduced 81.22%
7,229 Common Stock
Jan 07 2026
BUY
Exercise of conversion of derivative security
$250,713 $8.02 p/Share
31,261 Added 44.82%
38,490 Common Stock
Jan 06 2026
SELL
Open market or private sale
$5,075,118 $172.33 p/Share
29,450 Reduced 80.29%
7,229 Common Stock
Jan 06 2026
BUY
Exercise of conversion of derivative security
$236,189 $8.02 p/Share
29,450 Added 44.53%
36,679 Common Stock
Jan 05 2026
SELL
Open market or private sale
$13,480,249 $171.28 p/Share
78,703 Reduced 91.59%
7,229 Common Stock
Jan 05 2026
BUY
Exercise of conversion of derivative security
$631,198 $8.02 p/Share
78,703 Added 47.8%
85,932 Common Stock
Dec 04 2025
SELL
Open market or private sale
$1,564,484 $148.18 p/Share
10,558 Reduced 59.36%
7,229 Common Stock
Dec 04 2025
BUY
Exercise of conversion of derivative security
$84,675 $8.02 p/Share
10,558 Added 37.25%
17,787 Common Stock
Dec 03 2025
SELL
Open market or private sale
$2,962,751 $146.94 p/Share
20,163 Reduced 73.61%
7,229 Common Stock
Dec 03 2025
BUY
Exercise of conversion of derivative security
$161,707 $8.02 p/Share
20,163 Added 42.4%
27,392 Common Stock
Dec 02 2025
SELL
Open market or private sale
$7,121,346 $144.59 p/Share
49,252 Reduced 87.2%
7,229 Common Stock
Dec 02 2025
BUY
Exercise of conversion of derivative security
$395,001 $8.02 p/Share
49,252 Added 46.58%
56,481 Common Stock
Nov 05 2025
SELL
Open market or private sale
$2,928,519 $134.49 p/Share
21,775 Reduced 75.08%
7,229 Common Stock
Nov 05 2025
BUY
Exercise of conversion of derivative security
$174,635 $8.02 p/Share
21,775 Added 42.88%
29,004 Common Stock
Nov 04 2025
SELL
Open market or private sale
$6,750,909 $133.79 p/Share
50,459 Reduced 87.47%
7,229 Common Stock
Nov 04 2025
BUY
Exercise of conversion of derivative security
$404,681 $8.02 p/Share
50,459 Added 46.66%
57,688 Common Stock
Nov 03 2025
SELL
Open market or private sale
$12,136,239 $132.34 p/Share
91,705 Reduced 92.69%
7,229 Common Stock
Nov 03 2025
BUY
Exercise of conversion of derivative security
$735,474 $8.02 p/Share
91,705 Added 48.1%
98,934 Common Stock
Oct 08 2025
SELL
Open market or private sale
$1,518,062 $118.84 p/Share
12,774 Reduced 63.86%
7,229 Common Stock
Oct 08 2025
BUY
Exercise of conversion of derivative security
$102,447 $8.02 p/Share
12,774 Added 38.97%
20,003 Common Stock
Oct 07 2025
SELL
Open market or private sale
$1,590,330 $118.77 p/Share
13,390 Reduced 64.94%
7,229 Common Stock
Oct 07 2025
BUY
Exercise of conversion of derivative security
$107,387 $8.02 p/Share
13,390 Added 39.37%
20,619 Common Stock
Oct 06 2025
SELL
Open market or private sale
$2,309,667 $120.17 p/Share
19,220 Reduced 72.67%
7,229 Common Stock
Oct 06 2025
BUY
Exercise of conversion of derivative security
$154,144 $8.02 p/Share
19,220 Added 42.09%
26,449 Common Stock
Sep 16 2025
SELL
Open market or private sale
$2,251,712 $114.19 p/Share
19,719 Reduced 73.17%
7,229 Common Stock
HT

Herriot Tabuteau

Chief Executive Officer
New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM